Cargando…

Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson’s Disease

Parkinson’s disease (PD) is a highly prevalent neurodegenerative disease for which no disease-modifying treatments are available, mainly because knowledge about its pathogenic mechanism is still incomplete. Recently, a key role for lipids emerged, but lipid profiling of brain samples from human subj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xicoy, Helena, Brouwers, Jos F., Kalnytska, Oleksandra, Wieringa, Bé, Martens, Gerard J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031185/ https://www.ncbi.nlm.nih.gov/pubmed/31493240 http://dx.doi.org/10.1007/s12035-019-01733-3

Ejemplares similares

The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
por: Xicoy, Helena, et al.
Publicado: (2017)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020)

The Role of Lipids in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019)

Ghrelin alleviates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells
por: He, Xin, et al.
Publicado: (2021)

Protective effect of theaflavins on neuron against 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells
por: Luo, Zihua, et al.
Publicado: (2012)

Protective effect of Artemisia absinthium on 6-hydroxydopamine-induced toxicity in SH-SY5Y cell line
por: Rashidi, Roghayeh, et al.
Publicado: (2021)

Punicalagin Exerts Beneficial Functions in 6-Hydroxydopamine-Treated SH-SY5Y Cells by Attenuating Mitochondrial Dysfunction and Inflammatory Responses
por: Chu, Jianfeng, et al.
Publicado: (2018)

Sinapic Acid Protects SH-SY5Y Human Neuroblastoma Cells against 6-Hydroxydopamine-Induced Neurotoxicity
por: Tungalag, Tsendsuren, et al.
Publicado: (2021)

Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function
por: Wei, Lei, et al.
Publicado: (2015)

Nitroxide Radical-Containing Redox Nanoparticles Protect Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine Toxicity
por: Pichla, Monika, et al.
Publicado: (2020)

Evaluation of 6-Hydroxydopamine and Rotenone In Vitro Neurotoxicity on Differentiated SH-SY5Y Cells Using Applied Computational Statistics
por: Simões, Rui F., et al.
Publicado: (2022)

Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway
por: Xu, ZhengHu, et al.
Publicado: (2021)

Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells
por: Lai, Chun-Yi, et al.
Publicado: (2021)

The Encapsulation of Citicoline within Solid Lipid Nanoparticles Enhances Its Capability to Counteract the 6-Hydroxydopamine-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells
por: Margari, Andrea, et al.
Publicado: (2022)

Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson’s Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line
por: Tsai, Rong-Tzong, et al.
Publicado: (2020)

7,8,4′-Trihydroxyisoflavone, a Metabolized Product of Daidzein, Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells
por: Ko, Yong-Hyun, et al.
Publicado: (2019)

Vitamin K2 Modulates Mitochondrial Dysfunction Induced by 6-Hydroxydopamine in SH-SY5Y Cells via Mitochondrial Quality-Control Loop
por: Tang, Hengfang, et al.
Publicado: (2022)

Editorial: The Role of Lipids in the Pathogenesis of Parkinson's Disease
por: Baekelandt, Veerle, et al.
Publicado: (2020)

Involvement of Mu Opioid Receptor Signaling in the Protective Effect of Opioid against 6-Hydroxydopamine-Induced SH-SY5Y Human Neuroblastoma Cells Apoptosis
por: Eftekhar-Vaghefi, Shahrzad, et al.
Publicado: (2015)

MicroRNA-101 Regulates 6-Hydroxydopamine-Induced Cell Death by Targeting Suppressor/Enhancer Lin-12-Like in SH-SY5Y Cells
por: Omura, Tomohiro, et al.
Publicado: (2021)

Pharmacognostical Analysis and Protective Effect of Standardized Extract and Rizonic Acid from Erythrina velutina against 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells
por: Silva, Aline H., et al.
Publicado: (2016)

Compressional-Puffing Pretreatment Enhances Neuroprotective Effects of Fucoidans from the Brown Seaweed Sargassum hemiphyllum on 6-Hydroxydopamine-Induced Apoptosis in SH-SY5Y Cells
por: Huang, Chun-Yung, et al.
Publicado: (2017)

6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
por: Magalingam, Kasthuri Bai, et al.
Publicado: (2022)

Evaluation of the Combination of Metformin and Rapamycin in an MPP(+)-Treated SH-SY5Y Model of Parkinson's Disease
por: Norradee, Chureerat, et al.
Publicado: (2023)

Baicalein Prevents 6-Hydroxydopamine-Induced Mitochondrial Dysfunction in SH-SY5Y Cells via Inhibition of Mitochondrial Oxidation and Up-Regulation of DJ-1 Protein Expression
por: Wang, Yue-Hua, et al.
Publicado: (2013)

Neuroprotective effects of Withania somnifera in the SH-SY5Y Parkinson cell model
por: Wongtrakul, Jeerang, et al.
Publicado: (2021)

Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
por: Xicoy, Helena, et al.
Publicado: (2021)

The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy
por: Travaglione, Sara, et al.
Publicado: (2020)

Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model
por: Fu, Ru-Huei, et al.
Publicado: (2023)

Protective Effects of Jujubosides on 6-OHDA-Induced Neurotoxicity in SH-SY5Y and SK-N-SH Cells
por: Chen, Chao-Hsuan, et al.
Publicado: (2022)

Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism
por: Song, Ju-Xian, et al.
Publicado: (2012)

Clusterin levels in undernourished SH-SY5Y cells
por: Rodríguez-Rivera, Carmen, et al.
Publicado: (2021)

Neuroprotective Effect of Bergamot Juice in 6-OHDA-Induced SH-SY5Y Cell Death, an In Vitro Model of Parkinson’s Disease
por: Ferlazzo, Nadia, et al.
Publicado: (2020)

Correction: Tang et al. Vitamin K2 Modulates Mitochondrial Dysfunction Induced by 6-Hydroxydopamine in SH-SY5Y Cells via Mitochondrial Quality-Control Loop. Nutrients 2022, 14, 1504
por: Tang, Hengfang, et al.
Publicado: (2023)

The Impact of Differentiation on Cytotoxicity and Insulin Sensitivity in Streptozotocin Treated SH-SY5Y Cells
por: Bagaméry, Fruzsina, et al.
Publicado: (2021)

Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson’s disease
por: Krishna, Abhimanyu, et al.
Publicado: (2014)

Endogenous Morphine in SH-SY5Y Cells and the Mouse Cerebellum
por: Muller, Arnaud, et al.
Publicado: (2008)

Aspartame and Its Metabolites Cause Oxidative Stress and Mitochondrial and Lipid Alterations in SH-SY5Y Cells
por: Griebsch, Lea Victoria, et al.
Publicado: (2023)

Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine
por: Conte, Mariarosaria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vg6rfvo877sh05aph98e5ddj8r